Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already declare readOnlyHint=false, idempotentHint=false, destructiveHint=false, so the mutation and its safety profile are known. The description adds useful scope ('every currently available study', legacy label) but does not say what happens to studies already in the session or whether repeats duplicate entries, which matters given idempotentHint=false.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.